Comparing Aerobic to Resistance Training in Recovery From Cancer
NCT ID: NCT00237926
Last Updated: 2008-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2005-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
aerobic exercise
Exercise
aerobic or resistance training
2
Resistance Training
Exercise
aerobic or resistance training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
aerobic or resistance training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be within six months of having completed chemotherapy or radiation therapy for treatment for cancer as determined by the primary physician
* be ambulatory but sedentary (i. e., has not followed an exercise regimen of a minimum of 3 times per week for at least 20 minutes each session over the previous six weeks)
* have an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 asymptomatic) or 1 (symptomatic, fully ambulatory)
* be at least 18 years old
* be able to read and speak English
* have a medical statement from either the patient's primary care provider or the primary oncologist indicating that participation in the program is not medically contraindicated
Exclusion Criteria
* bone or joint destruction that could be aggravated with exercise
* severe cognitive impairment identified by either the patient's medical care provider or by the study team
* neuropathy-sensory common toxicity criteria (CTC) grade 3 (sensory loss or paresthesia interfering with activities of daily living) or grade 4 (permanent sensory loss that interferes with function) peripheral neuropathy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TriService Nursing Research Program
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The Geneva Foundation at Brooke Army Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stacey Young-McCaughan, RN, PhD
Role: PRINCIPAL_INVESTIGATOR
United States Department of Defense
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brooke Army Medical Center
Fort Sam Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N05-006
Identifier Type: -
Identifier Source: org_study_id